IDP Pharma

About:

IDP Pharma is a first in class drug for multiple mieloma treatment, to set up new discovery programs.

Website: http://www.idp-pharma.com/

Twitter/X: idppharma

Description:

IDP Pharma is a drug discovery company that develops first-in-class medicines (New Chemical Entities) directed to a novel class of therapeutic targets, intrinsically disordered proteins (IDPs). They are currently focused on exploiting new mechanisms of action to treat cancer diseases. Multiple myeloma is one of their priorities. IDP Pharma's efforts are directed towards promoting a real shift in cancer therapies to improve the lives of patients. To this end, the company has built an extraordinary committed team of experts in the field, supported by a professional advisory board, including IDPs and diseases experts, and business professionals.

Total Funding Amount:

$1.67M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Barcelona, Catalonia, Spain

Founded Date:

2015-01-01

Founders:

Santiago Esteban Martin

Number of Employees:

1-10

Last Funding Date:

2016-05-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai